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ABSTRACT
An estimated 2.1 million people in the US are estimated to have opioid use disorder. Medically
assisted treatment as an approach utilizes medication, counseling, and group therapy for
treatment of opioid use disorder and increases the effectiveness of other therapeutic
interventions. It has positive effects on treatment retention, and doubles the probability that an
individual will one day achieve abstinence. Medically assisted treatment addresses physical
symptoms of withdrawal, but it does not include the embodied experience. Dance/movement
therapy addresses the multilevel human experience in an approach to wellness.
Dance/movement therapy as a bidirectional modality uses movement and body-mind
connectivity to promote the integration of the emotional, social, cognitive and physical self to
improve health and wellbeing.

Keywords: dance/movement therapy, medically assisted treatment, mind-body pathway,
neuroplasticity, substance abuse, opioid use disorder, addiction treatment
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Opioids are nondiscriminatory. They affect users regardless of sex, age, gender, race,
ethnicity, socio-economic, or socio-cultural status. The National Institutes of Health (2019)
report that 21-29% of the patients who are prescribed opioids end up abusing them. Of these,
eight to 12% develop opioid use disorder, and four to six per cent of those will transition to
heroin. Use disorder is a condition which is considered to be a chronic lifelong disruption of
normal physical or mental functioning with serious potential for consequences including
disability, relapses, and death (American Psychiatric Association, 2013). In 2017, according to
the Centers for Disease Control, 57.8% out of 100 people received new opioid prescriptions
(U.S. Opioid Prescribing Rate Maps, 2018). This number is down significantly from its peak in
2012, but it still illustrates a staggering amount (191,218,272) of new prescriptions.
Approximately 2.1 million people in the US are estimated to have opioid use disorder (Yerby,
2019).
Opiate is a term referring to morphine, a naturally occurring substance derived from the
opium poppy plant (Brick and Erickson, 1998). The term opioid originally described man made
drugs which were chemically similar to opiates. Today the term opioid is applied more broadly
to include all substances - naturally occurring, semi-synthetic, and synthetic - that have similar
effects as morphine (Brick and Erickson, 1998). Opioids have been used for their medicinal
effects for thousands of years, but it is within the last 30 years that opioid addiction in the United
States has skyrocketed. From 1999 to 2017, 399,230 people in the US lost their lives to opioids
(Yerby 2019). In 2017 alone, 47,600 deaths (67.8% of all drug overdose related deaths) involved
opioids (Scholl, Seth, Kariisa, Wilson, Baldwin, 2019). The prevalence of opioid use has been
recognized as a national crisis with effects on public health, social and economic welfare, and
increased costs to the judicial and medical systems.

2

Booth (2013) traces the recreational cultivation of opium poppies back to Mesopotamia,
3400 BC. It is not until 1525 AD that a written account by Jerome of Brunswick identifies the
sedative qualities of opiates in surgical use. For thousands of years, the most basic raw form of
an opioid was used recreationally and medicinally by humankind. It was not until 1803, almost
300 years after the first mention of its surgical use, that morphine was isolated and identified by
Sertürner as the clinically important derivative of the opium poppy plant (Booth, 2013).
Sertürner’s discovery and subsequent experimentation paved the way for the prescription of
morphine for pain relief in the 1800’s. Production of synthetic opioids, including heroin (which
was first celebrated as a safe and less addictive alternative to morphine), began. Once it was
realized that natural and manmade opioids had severe addictive qualities, strict regulations were
implemented to mitigate the perceived danger (Rummans et al., 2018). The United States signed
the International Opium Convention in 1912 and instituted the Heroin Act in 1924, both of which
were designed to address rising addiction rates and to regulate the use of synthetic and natural
opioids as a matter of public safety (Rummans et al., 2018),. Despite known risks and instituted
laws, abuse of opioids persisted, production of new synthetic opioids continued to be explored,
and opioids were still viewed as the preferred prescription method for acute pain management
(Rummans et al., 2018).
It was not until the mid-1990’s that a sharp increase in the prescription rate of opioids
occurred. The beginning of this phenomenon is traced to a letter written in 1980 to the editors of
the New England Journal of Medicine (Rummans et al., 2018; Leung et al., 2017). The authors
criticized opioid restrictions for pain management and claimed that of over 11,882 patients; only
four had become addicted to opioids (Porter and Jick, 1980). This information directly
contradicted previous findings that opioids were highly addictive. The letter was subsequently
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cited over 600 times in favor for expanded capability to prescribe opioids for pain (Rumanns et
al., 2018; Leung, Macdonald et al., 2018). The next fifteen years saw a slow but steady
expansion of opioid prescription rates and a broadening of the applications to include treatment
of chronic pain (Rumanns et al., 2018). In 1995, further influence came in the form of an address
by Dr. James Campbell to the American Pain Society (Morone & Weiner, 2013). With concerns
that pain was undermanaged, he urged health care providers to regard pain as an important
clinical measurement, the presence of which impacted quality of life. Dr. Campbell advocated
for increased inquiry of pain which led to increased reporting. Before this time, pain assessment
was not a regular consideration. After his address, however, the practice of evaluating pain was
widely adopted, which evoked a reaction by physicians to provide treatment, particularly
treatment which included increased rates in opioid prescribing (Morone & Weiner, 2013). The
rapid expansion in the prescription of opioids was also pushed for by pharmaceutical companies.
In the 1990’s pharmaceutical companies promised that newly developed semi-synthetic and
synthetic opioids were much safer and that, unlike morphine or heroin, their use held little
danger for addiction (Opioid Overdose Crisis, January 2019). These claims were somewhat
deceptive in nature and this is attributed to the fact that there were no federal or industry
guidelines at that time (United States General Accounting Office, 2003). As an example,
OxyContin was aggressively marketed as a safe and suitable medication to treat long-term
chronic pain with few side effects, a false claim which eventually led to a fine of $634.5 million
(Rumanns et al., 2018). The mid to late 1990’s saw a culmination of these events: a poorly
founded claim which was widely cited and potentially misinterpreted, the idea of pain as vital to
health being relatively new and the reaction to provide care, and finally pharmaceutical
companies engaging in deceptive marketing practices. Overall prescriptions for opioids increased
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by two to three million each year between 1990 and 1995 (Rumanns et al., 2018). Following the
marketing push, annual prescriptions for OxyContin alone increased from 920,000 in 1997 to 7.2
million 2002 and in the same six year period the total number of opioid prescriptions increased
by 45 million (United States. General Accounting Office, 2003; Rumanns et al., 2018).
When taken as prescribed, opioids are effective for pain management; however, when
taken incorrectly there is a high potential for abuse. Throughout the course of this paper I will
use the terms use, abuse, addiction, and use disorder when referring to opioid consumption. Use
will be defined as consumption as intended. As opioids are a controlled substance, their intended
purpose is application according to a prescription obtained through a medical professional.
Abuse will be defined as consumption of prescription opioids in a manner other than prescribed,
or consumption of illegal opioids (heroin) and continuing to do either despite harmful or
detrimental effects. Continued abuse can lead to addiction or use disorder. These two terms are
used interchangeably throughout this paper and they are defined as the compulsion to continue
abuse, to be overwhelmingly involved in obtaining and consuming opioids with resulting
palpable and noticeable effect on daily life, and the inability to prioritize well-being over
continued consumption.

Multidimensional Effect of Opioids
The Diagnostic and Statistical Manual of Mental Disorders describes opioid use disorder
as “a problematic pattern of opioid use leading to clinically significant impairment or distress”
(American Psychiatric Association, 2013, p. 541). Diagnosis of opioid use disorder, according to
the DSM-5, requires two or more criteria that reflect impaired health or function over the course
of 12 months. Included in the diagnostic criteria are behavioral, physiological, and physical
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changes. This is significant because it suggests that opioid use disorder requires a
multidimensional understanding that considers the effects on the mind as well as the tangible and
intangible effects on the body.
There are many perspectives on why drug abuse occurs. Lewis (2015) argues that,
viewed through the lens of neurobiology, addiction could be considered an extreme reaction of a
normally functioning brain engaging in neuroplasticity. Neuroplasticity is a process in which the
brain is constantly engaging in which it learns, adapts, and changes. The neurobiological
perspective on addiction argues that long term exposure to opioids creates long term changes in
different neural systems (Beltran-Campos el at., 2015). Opioids affect the user by altering the
way the brain functions. They have been prescribed for centuries for their sedative and
intoxicating affects, for pain management, and even as antidepressants. It was not until 1973 that
scientists discovered specific receptors within the central nervous system to which opioids bind.
According to Brick and Erickson (1998), it was the discovery of opioid specific receptors which
led to the discovery of naturally occurring endogenous (occurring inside of the body) opioids
known collectively as endorphins. Endorphins are part of the body’s natural response to pain;
pain stimuli cause endorphins to flood the brain, bind with receptors, and provide pain relief
(Brick and Erickson, 1999). Further research led to the discovery of additional receptors which
are present throughout the central and peripheral nervous system; the primary opioid receptors
are mu (μ), kappa (κ), and delta (δ) (Leppä et al., 2006). While exogenous and endogenous
opioids work through the excitation of opioid receptors throughout the body, mu (μ) is the opioid
receptor that is the most responsive to the analgesic and intoxicating effects of exogenous
opioids (Brick and Erickson, 1998). In other words, it is only through excitation of these mu
receptors that opioids such as morphine, heroin, oxycodone, and codeine (among others) exert
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their pain relieving effects as well as their stimulating effects. In addition to the clinical benefits
of pain management, a significant dose of opioids can induce feelings of intense euphoria
(Savvas, 2013). These opioid induced alterations of the human system are also identifiable
within minutes after they enter the circulatory system (Brick and Erickson, 1998). The euphoric
feeling caused by exogenous opioids is much more intense than the endogenous opioids and this
is what is both so enticing and dangerous about their use. It was this discovery that illuminated
why the body has a very specific response to exogenous (occurring outside of the body) opioids;
they mimic naturally occurring chemical processes in the body (Brick and Erickson, 1998; Does
Long-Term Opiate Use Change the Brain? 2018).
Opioids are classified as psychoactive drugs, chemical substances that change brain
functioning resulting in temporary alterations in mood, consciousness, perception, cognition, or
behavior (Brick and Erickson, 1998). The specific impact on neurobiological processes is drug
and drug use dependent (Koob et al., 1998). This means different drugs, such as, alcohol,
tobacco, ecstasy, cannabis, and opioids affect the brain in different, but specific, ways. Criteria in
the Diagnostic and Statistical Manual of Mental Disorders factors in inter-individual biological
variability, which means that no two people taking a drug will have exactly the same response to
the drug (Brick and Erickson, 1998). The criteria is expansive enough to account for varying
symptoms demarcating opioid abuse, but not all people who misuse opioids will fit the abuse
profile. Keeping in mind this possibility for variability, there are many hallmarks specific to
opioid use and abuse which present neurologically, behaviorally, physically, and emotionally.
With opioid use several, areas of the limbic system (the brains center for processing
emotions) in the brain are indicated including the hypothalamus, the amygdala, the cortico
frontal cingulate system, and the mesolimbic dopamine system (Savvas, 2013; Berrol, 1992).
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The mesolimbic dopamine system, also known as the reward pathway, projects from the ventral
tegmental area in the midbrain to the ventral striatum of the basal ganglia in the forebrain
(Savvas, 2013). When the brain receives stimuli identified with a reward, the mesolimbic
dopamine system is activated; dopamine floods the brain and facilitates feelings of pleasure and
satisfaction (Does Long-Term Opiate Use Change the Brain? 2018). This is noteworthy because
the reward pathway is involved in identifying cues and facilitating reinforcement in rewardrelated learning and because of this it is believed to play a central role in the development and
maintenance of addiction (Koob et al., 1998). With opioids, the brain learns to identify feelings
of euphoria that are associated with opioid use as a reward. Any action which would lead to this
reward (such as turning down the street toward the dealer’s house) would be the cue which
triggers the reward pathway. Once triggered, the release of dopamine induces feelings of
pleasure or satisfaction and the result is reinforcement of the drug seeking activity. Through the
process of reinforcement, the reward pathway encourages addiction.
The brain consists of innumerable neuro synaptic pathways which are like a basic wiring
network (Lewis, 2015). These networks play a vital part in the action of neuroplasticity. For
example, walking a dog stimulates an established pathway in the brain and, each time this
activity is performed, the same pathway is activated. A new experience, such as feelings of
euphoria while taking opioids, can spark a new pathway, and it is the development of these new
pathways which prompt structural change in the brain’s wiring network. When the same pathway
is accessed repeatedly and is positively reinforced by dopamine, dopamine enhances formation
of the new pathway so that pathway is more deeply engrained (Lewis, 1999). The more deeply
engrained a pathway, the more firmly it is established as a procedure and eventually it becomes
habitual. This process occurs most significantly in the ventral striatum, which is the area
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responsible for motivation in pursuing rewards. With reinforcement, the newly established
pathway consolidates until there is a well-defined circuit for that reward. A healthy brain is
constantly engaging in this adaptive process of developing new circuitry, however, with opioid
abuse, long term exposure results in persistent reorganization of neuro synaptic connections
(Beltran-Campos et al., 2015). The new pathways that are created are strong and deeply
engrained and this makes them difficult to alter, which is counter to the action of neuroplasticity.
The result is the brain adapts to a very specific way of operating and is less capable of change.
As long term abuse affect synaptic neuroplasticity, it also diminishes dendritic spines (BeltranCampos et al., 2015). Dendritic spines aid in synaptic communication and are thought to play a
vital role in cognition as well as the reception of dopamine (Lewis, 2015). As they diminish, the
structure of the receptors which absorb dopamine become less effective. While the pathways
related to opioid abuse become entrenched, other pathways become weaker and gray matter as
well as synaptic density, in these now underutilized areas diminishes (Lewis, 2015). As the brain
becomes more singularly focused on opioid reward, previously enjoyed activities, like playing
with children or walking the dog, no longer hold as much value in comparison, and engagement
in these activities is neglected or stops. Here is the root of many of the behavioral changes
present with opioid abuse.
Behavioral changes which are indicative of opioid abuse may be difficult to notice in the
early stages, but they become more pronounced over time (Mayo Clinic Staff, 2018). These
changes may include regularly taking opioids in a manner other than prescribed, such as taking a
larger dose than prescribed or taking opioids for the way they make a person feel, stocking up on
medications to prevent running out, taking medications “just in case” when pain is not present, or
taking medications specifically to avoid symptoms of withdrawal (Brick and Erickson, 1998;
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Mayo Clinic Staff, 2018). Individuals may engage in drug seeking behaviors, including
attempting to procure duplicate prescriptions from multiple sources, borrowing medication, or
claiming to have lost prescriptions in order to stock up. Changes may also include altered sleep
patterns, mood changes, including excessive mood swings from excitement to belligerence,
utilizing poor judgement including engaging in dangerous situations or putting oneself or others
in harm’s way, and impaired sensory and motor skills (Brick and Erickson, 1998; Mayo clinic
staff, 2018). In examining the neurobiological effects of opioid use, it is clear that behavior
changes are congruent with changes within the brain, as opposed to separate conscious choices.
In opioid use disorder, behavioral changes escalate to include loss of control over
consumption even when there are physical or psychosocial consequences (Beltran-Campos et al.,
2015). Dependence, tolerance, and withdrawal are factors which contribute to this loss (Savvas,
2013). These require careful consideration because they manifest both neurologically and
physically and, in doing so, have an effect on the emotional and behavioral changes which
present. The abovementioned euphoria is by itself, a positively reinforcing factor for opioid
abuse. With continued abuse, the brain builds tolerance, which causes a reduction in the
pleasurable feelings that accompany use (Potenza et al., 2011). Physical dependence begins with
tolerance, which is when the brain is no longer responding to opioids the way it first did. As a
result, higher doses must be taken in order to reach the same level of euphoria. There is a direct
correlation between dose size and tolerance level: as one increases, so does the other.
Tolerance to opioids can grow quite quickly (Does Long-Term Opiate Use Change the
Brain? 2018). The brain acclimates to exogenous opioids, requiring increased dosages to achieve
the same analgesic or euphoric effects. As tolerance increases, the brain reduces its own
production of endogenous opioids as it has come to depend on the administration of exogenous
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opioids (Does Long-Term Opiate Use Change the Brain? 2018). This is the brain’s naturally
adaptive response; the brain comes to rely on this drug to function. When the drug-dependent
brain is deprived of the exogenous opioid it has become accustomed to, the brain experiences
withdrawal (Koob, Sanna, Bloom, 1998). Withdrawal is the physical and psychological response
which occurs when the brain has acclimated to a certain level of exogenous opioids and those are
no longer present. In withdrawal, endogenous opioids have lost their efficacy, as a chemical
change to the reward function of the brains means the system is no longer able to regulate itself
(Does Long-Term Opiate Use Change the Brain? 2018). The inability to regulate is a component
that makes withdrawal mentally difficult because brain functioning has been chemically altered.
Alternating episodes of euphoria and withdrawal provide both positive and negative
reinforcement which contribute to continued abuse (Does Long-Term Opiate Use Change the
Brain? 2018).) In time, pleasant motivations driving opioid use diminish while the negative
motivations increase and the behavior becomes less about reward (Potenza et al., 2011).
Dependence is now both physical and psychological and the adaptive response of the brain
means that behavior transforms from intentional to habitual and eventually to compulsive.
In addition to neurological and behavioral changes, opioid abuse also has physical
effects, and tolerance, dependence, and withdrawal play a big part. Physical responses to opioid
use can include decreased pulse rate and/or body temperature, constricted pupils, slowed reflexes
and stupor (Brick and Erickson, 1998). Speech may be slowed, low, raspy, or slurred, memory
and attention are impaired, and skin can be cool to the touch (Brick and Erickson, 1998). Also
possible are respiratory depression, constipation, nausea, vertigo, and drowsiness or sedation
(Savvas, 2013). First time users may experience some of these symptoms, such as intense nausea
or vertigo, which will decrease with prolonged exposure, while abuse can result in coma or death
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(Brick and Erickson, 1998). Just as tolerance increases with adaptions in the brain, tolerance for
many of the physical aspects of use also increases. Tolerance for pain relief, nausea and
respiratory depression rise, while only a limited increase in tolerance is seen for pupillary
restriction and constipation (Savvas, 2013). With even short-term use, symptoms of withdrawal
can present (Brick and Erickson, 1998). The physical presentation of withdrawal can be similar
to an intense bout of influenza (Brick and Erickson, 1998). Common symptoms include
insomnia, weakness, irritability, aches and pains, runny nose, chills, sweating, agitation, and
anxiety. In the later stages of withdrawal symptoms might include nausea, goosebumps, dilated
pupils, and abdominal cramps, or diarrhea. Savvas (2013) adds shaking and watery eyes to the
list of withdrawal considerations. Higher tolerance and greater dependence also mean increased
severity in withdrawal symptoms (Brick and Erickson, 1998). Intense negative physical feelings
are a component that makes withdrawal painful and also physically difficult because the opioid
dependent brain is no longer properly producing endorphins for pain management. With long
term abuse, the positive effects of opioids, such as euphoria and pain management, are no longer
the driving force behind use. In the case of abuse, compulsive actions reinforced by reward and
pleasure are continuously compounded by the threat of increasingly painful and intense
withdrawal symptoms.
The release of endogenous opioids in a stressful situation helps to regulate mood by
creating feelings of relaxation and increasing the sense of wellbeing (Does Long-Term Opiate
Use Change the Brain? 2018). As stated above, dopamine plays a significant part in the
emotional response brought on by external cues in reward seeking activities. Studies show that
emotional response is modulated by the endogenous opioid system (Leppä et al., 2006). Animal
studies show that opioids are implicated in changing emotional states and also in modifying
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emotional reactivity (Savvas, 2013). Savvas (2013) clarifies that emotional reactivity is the
emotional response to external stimuli while emotional states are the emotional response to
internal stimuli. As the functionality of the endogenous opioid system is usurped by exogenous
opioids, it follows that there will also be an effect on emotions.
Opioids have been prescribed as antidepressants and have mood enhancing properties
that have been shown to reduce stress; however, persons with opioid dependence rate higher on
measures of anger, depression, fatigue, anxiety, and confusion (Savvas, 2013) A person who is
experiencing stress or irritation who uses opioids can experience a boost to their emotional state
while the opioid’s endorphin-like action is experienced, but, after the effects wear off, negative
emotional states return quickly. These negative emotional states are a powerful motivator which
factor into compulsive opioid abuse (Koob et al., 1998). With abuse, the reduction of functioning
in the mesolimbic dopamine system causes emotional reactivity to be blunted. This includes both
elative and depressive reactivity and has consequences which extend to social and psychological
functioning (Savvas, 2013). The blunting effect of opioid abuse on emotional reactivity means
less access to a full range of emotions is available for reaction and emotional processing.

Treatments for Opioid Use Disorder
Just as there are different perspectives on factors leading to substance abuse, there are also
differing ideas of what treatment should look like. One treatment perspective is abstinence only,
in which substance users are encouraged to refrain from substance use. In the case of opioid
dependence, the detoxification process includes painful withdrawal symptoms and, for this
reason this method doesn’t have a high rate of success (National Institutes of Health, 2019). The
concept of ego fatigue is also something of note as it highlights the all or nothing approach that is
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central to abstinence and how taxing that process can be (Lewis, 2015). The idea here is the more
an object is withheld, the more the object is desired. Resistance as the primary focus in substance
abuse means focus and energy are put toward refraining from the object instead of reframing the
object. In individuals who have recently detoxified by abstaining, there is also a loss of tolerance
(Connery 2015). When relapse occurs with lowered tolerance, these individuals are particularly
susceptible to increased risk of overdose and death.
Another perspective to treatment is use of therapy or counseling which examines the “why”
of substance abuse. Two different approaches using this type of approach are substance abuse as
response to affect intolerance and substance abuse as a transitional object. Affect intolerance is
viewed as dealing with persistent inability to master emotions through substance abuse (Johnson,
1999). A person who lacks the capability to regulate emotions imbibes the substance as a means
of external modulation. As opioids have mood stabilizing effects, this approach might suggest
opioid abuse is to reduce stress. The perspective of addiction as transitional object suggests that
addiction is the response when there is a lack of, or an inability to utilize, internal or external
relationships (Johnson, 1999). In this case, the individual might have insufficient or poor
relationships and substance abuse becomes a substitute for having needs met. The substance also
acts as a constant object when relationships are unfulfilling or unstable. Again, due to mood
stabilizing effects, this approach might suggest that the positive feelings associated with opioid
abuse are a substitute for positive feelings in relationships. Both of these approaches focus on
identifying and resolving psychosocial problems which may be influencing abuse. Once
identified, problem thoughts and behaviors, high-risk circumstances, and triggers can be resolved
(Tinkler, Vallejos Bartlett, Brooks, Gilbert, Henderson, Shuman, 2005). The idea here is, through
learning and integration of information, alterations can be made to patterns of behavior, which
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can lead to changes in perspective, reinterpretation of emotional states, and development of
control. Learning about personalized factors and motivations, as well as examining individual
roots of addiction, also has positive effects on neuroplasticity (Lewis, 2015). This suggests that
positive neurological changes are a secondary benefit to the self-examination and learning
process. However, while addressing psychosocial factors by raising self-awareness, providing
insight to the client about their influences and motivations, and developing coping skills is a
critical step, these treatment perspectives don’t focus much on the neurological and physical
disruptions that are a part of opioid dependence.
The pharmacotherapy perspective addresses neurological and physical disruptions of opioid
dependence through medication. Pharmacotherapy interventions interrupt the cycle of opioid use
which is maintained due to alterations to motivational neurocircuitry (Potenza at al., 2011; Does
Long-Term Opiate Use Change the Brain?, 2018). This is achieved through introduction of
medications to normalize the chemical disruptions in the brain (Kosten, 2002).
There are two types of medication used to treat opioid abuse: either antagonist (naltrexone)
or partial agonist (methadone or buprenorphine) (Potenza et al., 2011). Naltrexone is an
antagonist, or opioid blocker, which binds to the mu receptors and, instead of stimulating, it
prevents activation (Connery, 2015). Unlike agonist and partial agonist medications, it does not
have risks of euphoria, withdrawal, or abuse (Kosten, 2002). Naltrexone works by binding to mu
receptors to prevent activation of the reward system; however, it provides no relief from
withdrawal (Kosten, 2002). Preventing all activation of the reward system means that, on the one
hand exogenous opioids will have no effect, but on the other endogenous opioids will also have
no effect. Additionally, before Naltrexone can be administered it requires total detoxification
from all agonist and partial agonist opioids and it is this, in combination with painful withdrawal
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symptoms, that makes administration and compliance poor (Kosten, 2002). A better option is
partial agonist medication. Partial agonist medications, methadone and buprenorphine, are
opioids themselves, which means they do have potentiality for euphoria, withdrawal, and abuse
(National Institutes of Health, 2019; Medications to Treat Opioid Use Disorder, n.d.). Similar to
the mu agonist opioids (morphine, heroine, oxycodone), partial agonists activate mu receptors in
the brain but they occupy these receptors for a longer period of time and with much less intensity
(Connery, 2015). The medication acts as a stabilizing tool to intervene immediately and to
control or diminish withdrawal and craving (Connery, 2015). Partial agonists satisfy the brain’s
increased need for opioid stimulation and provide a substitution when exogenous opioids are
absent and endogenous opioids are insufficient. Additionally, the use of partial agonists in
treatment also prevents a dramatic drop in physical tolerance. This is important because, in cases
of relapse when tolerance is tapered instead of dramatically reduced, there is a lower risk of
overdose and death (Connery, 2015).
The administration of long acting partial agonists with lower levels of psychoactive effects
allows for mitigation of the harmful effects of agonist opioids and it gives the brain a break. As
the brain is experiencing a reprieve from the cycle of abuse and withdrawal, recovery of synaptic
plasticity can occur (Beltran-Campos et al., 2015). This suggests an opportunity for a resetting of
the brain, allowing for healing and reengagement in the action of neuroplasticity which is
disrupted in long-term opioid abuse. After detoxification, the chemical alterations to the brain
which influence dependence and addiction begin to resolve, but this is a long process which
might take months or years (Kosten, 2002). The clinical effects of partial-agonist and antagonist
medication also differ for individuals (Connery, 2015). So, just as inter-individual biological
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variability factors into opioid effects, the effects of pharmacotherapy in treatment and recovery
vary from person to person.
Pharmacotherapy treatments are highly effective, but given the complex effects of opioid use
disorder, the most pragmatic approach is to work in tandem with psychosocial treatments
(Kosten, 2002). Just as opioids affect the user on multiple levels, it follows that treatment needs
to be multidimensional to address the effects of opioids on the whole person. According to the
National Institute on Drug Abuse, medically assisted treatment is a “critical component of opioid
addiction treatment” with scientific research establishing that medically assisted treatment
“increases patient retention and decreases drug use, infectious disease transmission, and criminal
activity.” (Olsen and Sharfstein, 2014, p. 1393). Studies show the most success in opioid use
disorder treatment has been found to come from pharmacotherapy combined with psychosocial
interventions, behavioral therapies, and mindfulness-based therapies (Connery, 2015; Potenza at
al. 2011).
The term medically assisted treatment describes an approach which utilizes medication,
counseling, and group therapy for treatment of opioid use disorder (Does Long-Term Opiate Use
Change the Brain?, 2018). Ideally, it involves a multidisciplinary team including physicians,
counselors, nurses, case managers, social workers, and the client (Tinkler et al., 2005). As opioid
dependence treatment is client-specific, the client is a vital member of their treatment team. This
is important because participation in a medically assisted treatment program is voluntary, and the
inclusion of the client in their own treatment increases their engagement as well as adherence to
treatment (Tinkler et al., 2005). This combination of modalities creates a simultaneous top-down
and bottom-up approach which allows for treatment of the whole person. While
pharmacotherapy addresses the neurological and physical, psychotherapeutic interventions are
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used to bring awareness to, and shift behavior from, unhealthy to healthy. Ultimately, the goal of
these combined interventions is to seize a window of opportunity in which the client’s
withdrawal symptoms are comfortably and safely managed and therapeutic interventions can be
implemented to develop sustained motivation to avoid relapse.
Comprehensive medically assisted treatment increases the effectiveness of other therapeutic
interventions, has significant positive effects on treatment retention, and doubles the probability
that an individual will one day achieve abstinence (Connery, 2015). Increased instances of
abstinence not only benefit the client, they have a positive influence on the societal cost as well.
In 2013, the total estimated social cost of prescription opioid use disorders (criminal justice,
incarceration, opioid dependent infants, treatment of infectious diseases, overdose treatment,
intoxication injuries, and loss of productivity including unemployment) was $78 billion with
only 3.6% ($2.8 billion) attributed to treatment (National Institutes of Health, 2019). Increased
retention in medically assisted treatment programs is shown to have outcomes of lower
depression, increased positive health outcomes, improved overdose mortality rate, reduced HIV
risk, reduced drug seeking behavior, reduced involvement in criminal activity, improved
employment retention, and improved psychosocial relations (Savvas, 2013; National Institutes of
Health, 2019). Weighing the societal costs of opioid abuse against the benefits of treatment for
the individual and society as a whole, it is clear that comprehensive treatment with the highest
positive outcomes for patient wellbeing has an overall benefit to society. Medically assisted
treatment plays a vital role in improving quality of life for those with opioid use disorder
(Potenza et al., 2011). Recovery involves learning new habits and methods of coping, but it also
must address the issues of possible relapse and help to prepare the individual who must learn
new strategies when facing cravings and social pressure to use (Potenza et al., 2011).
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Medically assisted treatment shows the highest rate of success and is supported by the World
Health Organization, the Substance Abuse and Mental Health Services Administration, and the
Institute of Medicine (Olsen and Sharfstein, 2014). However, there are many challenges to
implementing medically assisted treatment programs, including assumptions and
misconceptions, personal bias, stigmatization, situational barriers, and cost (National Institutes of
Health, 2019; Connors et al., 2013; Connery, 2015; Olsen and Sharfstein, 2014; Lewis, 2015;
Savvas, 2013). Many of these factors also overlap with one another, which compounds the
difficulty of obtaining and maintaining treatment.
There are many assumptions and misconceptions about medically assisted treatment which
prevents widespread implementation and these assumptions have largely to do with the
medications used. While the clinical effects of partial agonists are lower than agonist opioids, the
fact that they are all opioids leads to the assumption that medically assisted treatment is simply
replacing one drug with another; if individuals are engaging in long-term medically assisted
treatment using partial agonists then they are not actually in recovery. Lack of understanding for
the neurological and physical need for medically assisted treatment has slowed its adoption.
Treatment providers who share these views might be reluctant to prescribe this treatment, might
push for patients to exit or taper treatment too soon, or may administer treatment incorrectly
(Connery, 2015; National Institutes of Health, 2019). This then fuels the ill-formed
misconception that medically assisted treatment is ineffective. Olsen and Sharfstein (2014) speak
also of the misconception that a person who has opioid use disorder can control their cravings;
relapses are really just choices that are indicative of weak character. The perception that
weakness and willpower of the individual are the biggest factors in abstinence enforces an “us
versus them” mindset in which the blame for use is placed completely on the individual (Olsen
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and Sharfstein, 2014). If the client is minimized in this manner, there is a possibility of creating
an untrusting environment which encourages dishonesty for fear of stigmatization. This again
stems from lack of understanding the need for medically assisted treatment and also highlights
possible personal biases toward those suffering from opioid use disorder. The result is that,
ultimately, access to effective care is limited and patients who would otherwise benefit from
treatment are harmed.
Stigmatization of opioid use disorder is another significant barrier to treatment (Olsen and
Sharfstein, 2014). This leads to opioid use disorder rarely being treated alongside mental illness
or medical disorders, and bot being of equally valued as part of psychological wellness. This
point of view ignores factors of physical and neurological dependence and historically has
distanced opioid abuse treatment from the rest of health care (Olsen and Sharfstein, 2014). This
separation means that substance abuse, physical health, and mental health are not weighed
equally. If primary focus is on mental health, then opioid abuse becomes secondary. When this
happens, the whole person is segmented into manageable pieces which are assigned priority. For
individuals with co-occurring diagnosis, there is danger that symptoms of opioid abuse may be
falsely attributed to mental health and vice versa. This can add to stigma, might minimize the
problem, and results in inadequate treatment.
Currently the World Health Organization recognizes access to medically assisted treatment
as a necessary part of healthcare (National Institutes of Health, 2019). While there has been
awareness of opioid abuse since the early 1900s, it was not until 2005 that partial agonist drugs
were added to the World Health Organization’s list of essential medications which should be
readily available and affordable as a standard part of healthcare (National Institutes of Health,
2019). This recognition has not been enough to overcome the misconceptions, stigma, and bias
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which prevent access to a scientifically supported treatment. In fact, by 2013, 50% of drug courts
still did not allow medically assisted treatment under any circumstances (National Institutes of
Health, 2019). This is why a greater understanding of opioid use disorder as a medical disorder is
necessary; the view that treatment using partial agonist medication is opioid abuse continues to
prevent access.
There are situational barriers to medically assisted treatment which also affect widespread
implementation and access. Both methadone and buprenorphine are controlled substances, which
means they must be delivered within a federally regulated treatment program (Connery, 2015).
While there are federal guidelines in place which dictate their implementation, fewer than half of
private-sector programs offer this modality and, within those programs, less than a third of
eligible patients receive it (Connors et al, 2013, National Institutes of Health, 2019). This shows
a clear pattern of underutilization which shines a light on the problems that occur with limited
access. In early treatment, daily maintenance dosing is required to mitigate withdrawal
symptoms (Connery, 2015). This is an easy task with an inpatient population but, for individuals
who are responsible for bringing themselves to a treatment facility for maintenance dosing,
challenges with transportation, location, and scheduling could add to the burden of accessing
treatment.
Barriers also differ for different portions of the population. For example, members of the
military experience a higher rate of use and abuse of opioids (National Institutes of Health,
2019). This often happens because opioids are used in treatment of depression, posttraumatic
stress disorder, chronic pain, and are also abused in instances of high stress. The Veterans Health
Association does acknowledge partial agonist medications as the first line of treatment in opioid
use disorder, but only a quarter of patients are recorded as participating in these programs
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(National Institutes of Health, 2019). For incarcerated populations, historically, access has been
limited or sometimes prohibited by the judicial system (Olsen and Sharfstein, 2014). In 2015, the
Office of National Drug Control Policy dictated that state drug courts which receive federal
grants must not deny individuals access to treatment programs using partial agonist medications
and must not mandate that an individual cease use of prescribed partial agonist medications as a
condition of court (National Institutes of Health, 2019). This is especially important as
incarceration carries its own stigma. Denial or lack of access to medically assisted treatment
programs forces incarcerated individuals struggling with opioid use disorder to detox painfully.
In a situation where individuals have been stripped of much of their human rights, this practice
turns detoxification into an additional punishment. Individuals without access to these programs
while incarcerated have a twelve times higher fatality rate linked to loss of tolerance upon
release and relapse, higher reincarceration rates, higher return to criminal activity, and higher
instances of risky behavior contributing to instances of HIV, and hepatitis B and C (Olsen and
Sharfstein, 2014; National Institutes of Health, 2019). Incarcerated persons with access to
medically assisted treatment while incarcerated are shown to have the highest engagement in
treatment (National Institutes of Health, 2019). According to the National Institutes of Health
(2019), 68.6% of these individuals enter community-based medically assisted treatment
programs post release while only 7.8% of individuals who receive counseling while incarcerated
and a referral post incarceration to a medically assisted treatment program participate. The
numbers show that earlier engagement in treatment increases the likelihood of continued
participation and success. One month after release, 27.6% of those who had access to medically
assisted treatment test positive for illicit opioids compared to 62.9% of those who received only
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counseling and 41% of those who received counseling and referral (National Institutes of Health,
2019).
Language which is currently used to describe aspects of opioid use disorder treatment can be
potentially stigmatizing or pejorative (Olsen and Sharfstein, 2014). Terms like junkie carry
weight and imply character judgement. Hopefully, junkie isn’t a term used in the treatment
setting, but in the case of clients using partial agonists, test results showing the presence of
opioids are labeled as positive. Labeling these results positive or negative is not that far from
labeling them dirty or clean; terms which also imply a value judgement. The term detoxification,
with or without medically assisted treatment, implies that as long as opioids are detectable in the
system, a person is toxic (Olsen and Sharfstein, 2014). Similarly, saying a person is “getting
healthy” indicates that while in recovery, they are not healthy (Olsen and Sharfstein, 2014).
Lewis (2015) further observes that even the word recovery carries negative connotations.
Recovery implies trying to go back to a place or to get back what we’ve lost. Treating
neurological, physical, and psychological changes resulting from opioid use disorder involves
embodied development into a new place of understanding. Therefore, especially in healing
spaces, language should be carefully considered in its capacity to mirror or perpetuate
stereotypes.

Multidimensional Effect of Dance and Dance/Movement Therapy
Movement is universal to all human beings and is defined as physical motion between
points in space. Capability, mobility, and expression may vary widely, but even in stillness there
is movement: in breath, in the beating of the heart, and in the tiny dance that is the in constant
negotiation with gravity. Dance can be defined as a sequence of intentionally organized,

23

culturally patterned movement, which is performed in a specific order to rhythmic stimuli. Dance
has been utilized by humankind for countless centuries for socialization and communication as
well as for healing of mind (enhancing expression and emotional release), body (for fertility,
birth, sickness, and death), and soul (religious and spiritual celebration) (Quiroga Murcia et al.,
2010; Jeong et al., 2005; Ritter, and Low, 1996; Rossberg-Gempton and Poole, 1992). Dance can
be presentational, interactive, for physical exercise, improvisational, or done as a solo activity.
Dance can exist in many forms including performative, social, solo, and structured partner dance.
When dance and movement are examined closely, there are many benefits including physical,
psychological, emotional, and neurological.
Movement in physical activities, such as exercise, often has a focus on health benefits
such as improved physical fitness (Hui et al., 2008). Exercise is comprised of motoric
movements which are completed for a specific purpose, but movement in dance incorporates
dynamic aspects of movement simultaneously for full body engagement. An example of the
intentional marriage of dance and exercise for physical health is aerobic dance. Aerobic dance
can be any kind of dance done to music in a choreographed sequence of movements for the
purpose of improving cardiovascular and muscular health. Studies documenting the benefits of
aerobic dance observe numerous physical benefits including increases in cardiorespiratory
endurance, coordination, and dynamic balance, as well as decreased body fat, lowered resting
heart rate, and lowered blood pressure (Hui et al., 2008). It is clear that there are many physical
benefits which are observed in this form of intentional movement. Studies also show
psychological benefits in aerobic dance including improved self-esteem, improved mood, and
increased social contact (Hui et al., 2008). This is noteworthy because psychological benefits,
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while identifiable, are not the primary focus of this type of movement as physical health is the
goal.
As a multidimensional activity, dance is effective in improving physical, emotional, and
psychological health. Of note are studies on social and structured partner dance forms which
show many of the same benefits to physical health as aerobic dance, but also demonstrate
increased focus on psychological and emotional aspects (Hui et al., 2008; Quiroga Murcia et al.,
2010; Hackney et al., 2007; Kiepe et al., 2012). Emotional benefits include reductions in anxiety,
negative thoughts and feelings, and stress (Quiroga Murcia et al., 2010). Quiroga Murica (2010)
reported significant improvements to emotional states in the time leading up to dance
interactions which remained after the activity had ceased. This suggests long lasting changes to
emotional states in relation to dance. Psychological benefits of dance include increased sense of
self-worth, increased mental well-being, and improved sense of belonging (Quiroga Murica et
al., 2010). Increased sense of belonging may be attributed to the relational nature of social and
structured partner dance. As an example, structured partner dances, such as tango, involve
physical interaction, as movement is in direct relation to another body (Hui et al., 2008; Hackney
et al., 2007). In addition to engagement through dynamic balance, variations in speed, and spatial
awareness, tango requires close proximity and joining rhythmically with another person.
Rhythmicity supports connection and strengthens social bonds, while encouraging sympathy and
understanding both individually and culturally (Quiroga Murcia et al., 2010). This development
of relationships expands social networks and builds community by providing the opportunity for
connection, encouragement, and the experience of external support systems, all of which have
correlating positive emotional and psychological effects.
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While there are numerous physical, psychological, and emotional benefits which result from
movement and dance, there are also neurological indications to consider. Long term dance
training, for example, shows increased brain activity and increased gray and white matter in the
brain (Karpati et al., 2015). Studies comparing brain activity of professional dancers to nondancers, and those comparing repetitive movement to dance interventions in non-dancers found
increased gray and white matter in the participants who were engaging through dance (Karpati et
al., 2015; Rehfeld et al., 2018; Müller et al., 2017; Teixeira-Machado et al., 2019). These studies
indicate structural change to the brain as a direct byproduct of dance. In addition to structural
change, functional changes are observed, including increased balance, significant improvement
in memory, increased attention, and improved psychosocial factors (Teixeira-Machado et al.,
2019). Taken together, these structural and functional changes comprise the essence of
neuroplasticity.
A key facilitator in neuroplasticity is brain-derived neurotropic factor, a protein which is
secreted in the central nervous system (Mang et al., 2013; Müller et al., 2017; Dayan, and Cohen,
2011; Rehfeld et al., 2018, Dayan and Cohen, 2011). It plays a vital role in neuroplasticity and
neurogenesis by assisting dendritic spines growth and by facilitating persistent strengthening of
synapses (Mang et al., 2013). Brain-derived neurotropic factor is secreted in one of two ways:
continuously, regardless of external influence, or in response to activity (Mang et al., 2013). This
means that its role in the action of neuroplasticity can be directly affected through movement.
Studies which compare repetitive movements, such as exercise, to dance and their efficacy on
neuroplasticity, indicate that dance has greater influence (Müller et al., 2017; Teixeira-Machado
et al., 2019). This suggests that type of movement plays an important part. Dance as a multisensory activity incorporates ever changing steps, rhythms, coordination of multi-bodily
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expression, and requires learning (Müller et al., 2017). The evolving nature of dance allows for
full sensory engagement through the body to integrate several brain functions simultaneously.
Movement is the core component of both dance and dance/movement therapy so it
follows that benefits of movement and dance are inherent to dance/movement therapy (Kiepe et
al., 2012). The defining difference is the transactional relationship between the trained
dance/movement therapist and the client. This relationship is the key piece through which
facilitation of understanding of the multidimensional relationship between mind and body
occurs. Dance/movement therapy is a bidirectional modality, body to mind/mind to body, that
uses movement and body-mind connectivity to promote the integration of the emotional, social,
cognitive and physical self to improve health and wellbeing.
Early dance/movement therapists such as Trudi Schoop, Marian Chace, and Liljan Espanek
believed in the reciprocal relationship between mind and body (Rossberg-Gempton and Poole,
1992). Schoop viewed the body as the tangible expression of man’s lived experience and
believed that alterations to the physical would manifest in the cognitive. Chace explored
nonverbal expression in treatment and noted that patients who had psychological barriers
affecting communication used the body to communicate. Espanek promoted the body and selfexpression through movement as a way to gain knowledge of the self (Rossberg-Gempton and
Poole, 1992). Dance/movement therapy’s core tenet is what happens in the mind is reflected in
the body and what happens in the body is reflected in the mind. This focus on the body-mind
connection is not singular to dance/movement therapy. Early explorations of the reciprocal
relationship between the body and affect can be traced to Charles Darwin (Rossberg-Gempton
and Poole, 1992). Darwin suggested that movement was expressive of states of mind. This idea
has been explored and expanded by psychoanalysts, psychologists, and dance/movement
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therapists alike who have studied the relationships between movement and emotional
access/expression, postural shifts, body positioning, muscular tension, facial expression, and
gesture, and what information these all convey. Throughout the 1900s, researchers observed
positive correlation between the mind and body and concluded that movement provided valuable
diagnostic information pertaining to emotional and psychological wellbeing. In recent years,
developments within neuroscience have begun to illuminate this connection more clearly
(Homann, 2010; Rossberg-Gempton and Poole, 1992). This is of significance because
verification of the body-mind link aids in understanding why a body based approach is valuable
and effective as a mechanism of change.
Participants in dance/movement therapy report positive psychological changes including
improved quality of life, self-esteem, mood, and affect, with reductions in paranoid ideation,
anxiety, psychological distress, and psychoticism (Ritter and Low, 1996; Kiepe et al., 2012;
Jeong et al., 2005; Koch et al., 2013 cited in Acolin, 2016). These are examples of impacts on
psychological function, which are achieved by engagement of the brain through the body
(Berrol, 2006). In addition to the psychological, dance/movement therapy demonstrates
behavioral, emotional, and neurological applications (Ritter and Low, 1996; Kiepe et al., 2012;
Jeong et al., 2005; Acolin, 2016). Following are three examples which each list an intervention
with a primary goal. Please note that, because dance is a multisensory engagement, these
interventions have multiple applications. The first example is of neurological significance. Kiepe
et al., (2012) and Acolin, (2016) observed that interventions using dance/movement therapy in
people with depression showed an increase in neurohormones which play a role in stabilizations
of the sympathetic nervous system. Here is a measured positive neurological effect of
dance/movement therapy. The second example is of emotion. Dance/movement therapy work
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with mildly depressed adolescents showed modulating effects on dopamine and serotonin levels,
including stabilization of the sympathetic nervous system and increased relaxation (Jeong et al.,
2005). As noted earlier, dopamine plays a vital role in the reward systems of the brain; therefore,
this indicates correlating effects on mood. The final example is of behavior. Movement and
rhythm used in a group process encourage entrainment, or synchronization, with the group,
which when achieved, fosters a sense of becoming part of a collective (Berrol,1992). This
joining in rhythm strengthens interpersonal communication and expands nonverbal
communication. Combined, these examples demonstrate tangible clear additional benefits to
dance/movement therapy which come from development of the therapeutic relationship, and its
role in supportive processing of embodied experience.
Dance/movement therapy is also used in the management of chronic pain. Acute, short term
pain is an important signal that alerts the individual to stress or injury. Chronic pain is long term,
lasting weeks or years, which can be detrimental to work, behavior, social relationships, and
mental health (Shiel, 2018; Boudreau et al., 2010). Chronic pain is an important factor to
consider when working with people with opioid use disorder. Conventional pain management
strategies, including increased prescribing rates of opioids, have contributed to the current opioid
epidemic and this means there is a good chance that pain will be a compounding factor in the
treatment of opioid use disorder. Quiroga Murica et al., (2010) observed that dance was useful in
both pain reduction and in accepting physical impairments. Further study by Shim, Goodill, and
Bradt (2019) examined multiple dance/movement therapy interventions for chronic pain and
identified five key mechanisms that were beneficial in treatment: activating self-agency,
connecting to others, connecting to self, reframing, and enhancing emotional wellness.
Participants of the study identified that the most important feature of dance/movement therapy
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was the nonjudgmental space which allowed for self-directed structure (Shim, Goodill, and
Bradt, 2019). Left unaddressed, chronic pain reduces movement, causes detachment, and limits
capability to engage in life in a meaningful way (Shim et al., 2019). There are many studies on
the use of dance/movement therapy as an effective tool for management of chronic pain which
are outside the scope of this paper.

Dance/Movement Therapy in Addiction Treatment
The holistic perspective on treatment of opioid use disorder includes considerations of
emotional, physical, and social wellbeing (Breslin et al., 2003). As a psychotherapeutic modality,
dance/movement therapy uses the body to address emotional and psychological effects of opioid
abuse including fear, control, denial, anger, ambivalence, loss, and shame (Milliken 1990, 2008).
This kinesthetic exploration through the body includes engagement of not only the physical, but
neurological aspects as well. Dance/movement therapists who have knowledge of the
multidimensional effects of opioid use disorder bring enhanced awareness of what the client may
be experiencing and how the body-mind pathway has been affected. They engage the whole
client in their individual expression and make room for the varying manifestations of addiction.
Critical components to their engagement are knowledge of the hallmarks of opioid abuse as well
as careful attention paid to countertransference (Thomson, 1997). It is important for the
dance/movement therapist to have knowledge both about themselves in relation to opioid use
disorder and of the functioning of opioid use disorder. Knowledge allows for increased insight
and distinguishing whether reactions are due to characteristics of the individual or to aspects of
the disorder. This is important because the individual is not the disorder and stigma surrounding
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opioid abuse sometimes detracts from this fact. An example of this might be a dance/movement
therapist working with a client to grow emotional expression using movement intervention to
expand the kinesphere. In this case, awareness of the emotionally blunting effects of opioids
increases the awareness that what might look like resistance on the part of the client who is
having difficulty connecting emotionally, is really a side effect of opioid abuse or
pharmacotherapy treatment.
Dance/movement therapy holds an important space in treatment for co-occurring
diagnosis. In instances of dual diagnosis, it is common that substance abuse is treated as a
secondary concern. This is problematic because concurrent opioid abuse and psychological
disorder may exacerbate each other or have interrelated symptoms (Thomas, 1997). Dividing the
person in a way which positions mental health as more important, results in the inability to
differentiate what is a symptom and what is an effect. An example would be a person who
experiences a traumatic event which results in posttraumatic stress disorder and is prescribed
opioids for pain management. The calming effect and euphoric feelings received from opioid use
have become preferential to negative emotional states, and opioid abuse becomes an element. In
this example, if the psychological components of posttraumatic stress disorder are viewed as the
important pieces of the puzzle, attention to abuse is lessened, manifestations of withdrawal are
minimized, and symptoms such as agitation or self-destructive behaviors may be falsely
attributed to posttraumatic stress disorder when they are really indicative of physical and
psychological dependence. The result is that necessary parts of the person are missed.
Dance/movement therapy creates an environment which allows the body to be experienced
alongside the mind and sheds light on the complete picture. Awareness of physical
manifestations of pain and opioid addiction as well as specialized knowledge of movement and
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patterning of the body makes dance/movement therapists uniquely poised to identify and
advocate for co-occurring substance abuse as equally important to psychological health (Kirane,
2018). By combining knowledge of hallmarks of opioid abuse and attuning to the embodied
experience, dance/movement therapists identify and become voices for the whole human being.
Dance/movement therapy brings with it all of the possible creative elements of dance and
expressive movement (Thomson, 1997). As an artistic expression, dance is unique because of its
transitional nature; it lives only in the moment that it exists, the here and now. Naturally, it
follows that, as a modality, dance/movement therapy reflects the present moment (Kirane, 2018).
What is happening emotionally, psychologically, and physically is all simultaneously present in
the space. When opioid abuse has taken the individual outside of their own recognition or their
body out of their control, dance/movement therapy is a vehicle that can bring them back to right
now by reacquainting them with the physical. This involves rediscovering the natural sensations
or signals that come from the body (Breslin et al., 2003). Raising conscious perception of what is
occurring in the body stimulates identification of sensations that have been blocked or distorted
by opioid abuse. Bringing awareness to the present moment, or grounding, is achieved through
intentional focus on the physical to give context to the body in space. Interventions can use
sensory awareness (use of sight, smell, hearing, touch, and taste) or physical action. Intentional
eye contact, weight sensing, use of the kinesphere (personal space), or use of space (external
environment) are all possibilities (Thomson, 1997). A sensory exercise which stimulates the five
senses requires the individual to pay attention to what is currently occurring in their environment
while a physical exercise requires a more internal investigation. Guided meditation is used as a
physical exploration for breath awareness, leading the individual to observe the depth, quality,
and control of breath. Self-touch, both physical and sensory, is used to bring attention to the
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posture, position, and presentation of the body by providing real-time tactile feedback. These
exercises serve to ground in the present and to encourage increased mindfulness for inner body
awareness, or interoception. Interoception, or processing of the internal state of the body, is a
valuable tool in substance abuse as loss of control and disconnection from the body leads to
distrust of bodily cues (Hindi, 2012; Price & Hooven, 2018). Body-felt experiencing is an
essential way to discover internalized sensations and feelings. Coming back to the physical and
learning to listen to it helps individuals to distill what they are experiencing and feeling in the
present moment.
Structure is a key ingredient which transforms the therapeutic space into a safe
environment. When clients feel safe, they can explore trust, support, and build or test their own
strengths and confidence through movement (Wagner, 1982; Kirane, 2018). One way to build
structure is use of music as the rhythmic impetus for the beginning and end of the group. Another
is to create specific movements as a ritual to mark the start or end of the group. Both of these
ideas create an anchor for the member which allows them to orient themselves in relation to the
timeline of the group. Music can be used for structure during a specific investigation. In the case
of opioid use disorder, music which is identified as eliciting feelings of euphoria gives the client
an opportunity to explore feelings in a controlled manner (Thomson, 1997). Music holds the
structure while movement explores a state which is sought after and familiar but is ultimately
maladaptive. The capacity to experience euphoria, which was previously tied to maladaptive
behaviors, gives the client a tool to change the narrative of those feelings and to develop adaptive
coping skills through experiencing. Music can also be used for structure through the course of
the group. A steady rhythm provides support for moving together, and, as noted above, rhythmic
entrainment encourages connection, community, and nonverbal communication. Another way
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that structure can be used in a group is to quite literally gather in a structure, such as standing in
a circle. In the circle, all members are able to see and be seen simultaneously. They are
supported on each side and no member is singled out, which allows all members to come to the
circle as equals. Once structure and safety are established, there is space for supported risk taking
and exploration (Milliken, 2008; Thomson, 1997). Altering the structure of a group over time,
beginning with well-structured sessions moving toward client-directed sessions, creates an
opportunity for clients to take the risk of being a leader (Wagner, 1982). Practicing leadership in
a supported environment empowers the client through authorship of choices, experiencing
responsibility of leading others, and inspiring confidence that clients can craft their own
structure, which they can then carry into their lives.
Knowledge of the self and learning new methods of coping are critically important to
addiction treatment strategies (Lewis, 2015; Wagner, 1982). Explorations which examine
behavior patterns, such as risky exploits or rituals of use, build self-awareness and broaden
understanding of behaviors (Kirane, 2018). Understanding also assists clients in discerning
reality and provides encouragement to take responsibility for the self, which is a vital step to
ultimately changing behavior. These concepts are particularly relevant because they focus on
learning. Learning about the self serves to educate clients on the motivating factors behind
addiction. Development of a self-narrative through movement is an intervention that can be used
to explore addiction as a transitional object. By bringing together movement and verbalization, a
pathway is created which gives context to the subjective experience of the individual (Wagner,
1982). The examination and integration of a precipitating episode, such as relationship disruption
or trauma, allows the individual to contextualize an event within their life timeline. Giving
context can assist clients in moving from a disorganized and unproductive place to a
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knowledgeable place where they can make proactive decisions (Breslin et al., 2003). An
intervention addressing addiction from the perspective of affect intolerance includes expansion
of emotional expression through movement. Substance abuse often develops as a way to avoid
overwhelming feelings of the present which leads to disengagement. In this intervention,
kinesthetic expansion, muscle tension, and movement quality are used to explore emotional
expression on the body level. Physical exploration allows participants to face emotions which
may be uncomfortable or unfamiliar and to observe how or if those emotions change through
movement (Thomson, 1997). Embodied emotional experiencing without assistance of exogenous
opioids also encourages participants to build tolerance for uncomfortable feelings and to gain a
sense of mastery over those feelings on the body level (Milliken, 1990). Expansion of bodily
skill and engagement of emotions through movement makes feeling states more consciously
available to the mind. Once feelings are identified, participants can work to develop ways of
responding, which fosters identifying what their needs are in the moment (Thomson, 1997). This
process allows clients to practice agency in emotional regulation on a body level without the aid
of substances. It also seeks to change understanding of motivations by crystalizing needs, which
leads to increased clarity as to how to meet needs without chemical modulation.
Opioid use disorder is a stigmatizing and isolating experience in which individuals are
disconnected from their bodies and from relationships. As a transitional object, addiction is often
the substitute for healthy relationships both within the self and with others (Milliken, 2008). This
makes relationship development an indispensable aspect of the treatment process. Practicing
relationships serves to increase capacity for development of connections which are a necessary
piece of moving forward in treatment. An important aspect of relationships is trust.
Dance/movement therapists develop trust through the use of kinesthetic empathy and mirroring
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(Milliken, 2008). In this instance, nonverbal communication is their way to let the individual
know that they are seen and that they are accepted. Nonverbal communication facilitates a safe
haven for exploration and expression when clients are unable, or hesitant, to be themselves by
building a bridge from verbal to non-verbal (Breslin et al., 2003). Nonverbal communication
extends an invitation to enter into the relationship. Now relationships can be developed in many
ways, through the use of rhythm, parallel play, in dyads, or in groups. Participation in a group
offers individuals the latitude to develop different relationships: to music, to individuals, to self,
and to the group as a whole (Thomson, 1997). This engenders the chance to expand trust beyond
a singular therapeutic relationship (Milliken, 2008).
Groups generate a space in which clients can discover new ways of relating to others
while concurrently developing awareness of sensations on the body level (Wagner,1982). The
group allows for skill practice of being in relationship with others while experiencing emotions.
This process is an invaluable tool which offers a multisensory situation to address psychosocial,
emotional, and physical aspects of interaction. Groups furnish opportunities for community,
structure, and interpersonal interaction and allow participants the space to find what works for
them through experiencing. Mirroring, as a group intervention, allows members to see
themselves reflected by the group (Milliken, 2008). This enables members to witness themselves
more clearly and to also observe how they are perceived by others. Mirroring further gives
members the chance to recognize familiar aspects of emotion or movements in others, which
signals to them that their experience is not singular. Having a chance to experience shared
feelings fosters emotional growth, connection, sense of belonging and encourages positive
physical feelings (Milliken, 1990). These interventions can be used to increase emotional and
bodily awareness, which have been altered by opioid abuse, and to create a sense of connectivity.
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Exploring group connectivity further, non-verbal interventions which use shared leadership in
group movement serve to encourage feelings of support and relatedness, it allows participants to
make directive choices through movement, and it offers a way to practice attunement (Thomson,
1997). Participants are empowered yet supported by the group and are challenged to listen on the
body level. The group also offers members a place to explore alternative behaviors through
direct physical experience (Milliken, 1990). For example, an intervention which looks at
behavior begins with development of a movement phrase representational of opioid abuse or
destructive patterns. That phrase is explored or expanded while paying attention to the bodily
sensations and emotions which accompany the movement. Once this has been established,
members move to explore patterns which ignite opposite emotion. The role of the group is to
provide a supported environment where members can explore feelings of comfort or discomfort
(Milliken, 2008; Thomson, 1997).
Structured play as an intervention can be used to define and strengthen
boundaries, practice empathy, explore interactions in a nonthreatening environment, examine
tension and aggression regulation, and to develop impulse control (Thomson, 1997). In
structured play, the group acts as a laboratory for participants where members are free to practice
adaptive behaviors and methods of coping (Milliken, 2008). It becomes a rehearsal space for
everyday life. The here and now aspects of dance/movement therapy combined with structured
play provides a platform for real-time development of adaptive coping skills (Thomson, 1997). A
client who has internalized messages that they were weak for continuing to abuse opioids would
benefit from an intervention constructed around the concepts of strength and success, such as
pushing or using shared weight to accomplish a goal. In this instance they would need to exert
themselves. The experience of embodied response and success helps the client to see themselves
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as strong and capable. This exploration can lead to the illumination of unused qualities of
movement and the possibility of reframing the self-view through re-experiencing. This might
expand their possibilities for emotional expression and make space for discovery of another
dimension of the self (Thomson, 1997). Practicing in structured play allows participants to play
with self-expression and to experience relationships through verbal and non-verbal movementoriented experiences (Milliken, 1990). Use of movement stimulates the imagination, allowing
participants to visualize different ways of moving, and opens the door new possibilities.
Discussion
Dance/movement therapists are whole-person practitioners who harness the power of the
body-mind pathway by crafting intentional, multisensory movement interventions. Their use of
attunement and kinesthetic empathy aids in the interpretation of movement, nonverbal
expression, behavior, and emotion. Through psychotherapeutic intervention, attention to body
awareness, and development of interpersonal and intrapersonal communication, dance/movement
therapists create a space which honors subjective experience. They also build relationships.
Through transactional relationship, therapists are able to craft movement interventions which
enhance the value of what dance and movement bring to the therapeutic space while adapting to
individual needs. This ability of shaping to encompass whatever is present in the moment speaks
to the flexible nature of dance/movement therapy and its ability to be conducted in a variety of
settings, with a wide range of populations and cultures.
As opioids exert their effects multidimensionally, it makes sense that a multidimensional
approach is needed for comprehensive treatment. Dance/movement therapy is well positioned
because it addresses the multilevel human experience in an approach to wellness. Examination
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and integration of psychological and psychosocial factors influencing addiction, complements
flexibility in meeting the needs of clients, and makes better investigators who are more open to
what is driving addiction. Having a general knowledge of different perspectives on addiction,
enhances awareness of biases, and complements the nonjudgmental nature of dance/movement
therapy. Additionally, a dance/movement therapist working with opioid abuse will benefit from
familiarity with the stages of change. There are six stages: precontemplation, contemplation,
determination, action, maintenance, and relapse (Connors et al., 2013). Each stage involves its
own unique set of tasks, attitudes, and behaviors (in precontemplation, there is no awareness of a
problem, with more perceived positives than negatives about opioid use, while in contemplation,
there is consideration that change is needed and what the consequences of change would be).
Dance/movement therapists are uniquely qualified to identify these stages through the body by
attuning to the client. Embodied movement through these stages reinforces the emotional and
psychological change on the body level.
Dance stimulates several brain functions all at once through multisensory engagement
(Teixeira-Machado, 2019). Kinesthetic interventions exploring spatial orientation, movement
coordination, balance, and endurance serve to increase the brains perception of one's physical
body and to orient one in space. Interventions which combine physical activity with sensory
enrichment through rhythm, increase nonverbal communication, and engage both body and brain
through interpretation of sound. These explorations allow for rhymicity, coordination and
regulation of movement in time with others, which increases community and strengthening of
social bonds (Quiroga Murcia, 2010). Rhythmic entrainment centered on natural rhythms, such
as heartbeat or breath, increases body apperception, develops interpersonal communication, and
allows for identification of the self in others. Physical movement also serves as a creative outlet
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for pent up anger, tension, or resistance (Milliken, 1990). Interventions exploring range of
emotional expression through kinesthetic expansion, muscle tension, and postural shifts,
encourages self-efficacy, and mastery of emotions, through the experience of being in charge of
the body and its actions.
Opioid use disorder requires being open to treating the whole person and not just the
piece that is addiction. Manifestation of opioid abuse is an overlapping, multisystem, onslaught
which makes segmented treatment an ineffective approach. Knowledge of interrelated processes
increases capacity to address, and enhances sensitivity for, the involuntary feelings of withdrawal
(dysphoria, pain, and malaise) as well as complicated psychological and emotional responses
(depression, agitation, loss of self-efficacy). Dance/movement therapists know that there is a
reciprocal action between the body and the brain and that separation of the whole into pieces is
antithetical to whole person healing. Knowledge of the functioning and interrelated presentations
of opioid abuse is especially important in co-occurring cases as it may be difficult to discern
whether symptoms are a result of opioid abuse or if they are a manifestation of something else.
In the instance of co-occurring diagnosis, dance/movement therapists can use their knowledge of
the body to observe, attune, and give a voice to indicators of opioid abuse By focusing on
embodied healing in any given moment, dance/movement therapy creates an inclusive method of
addressing all aspects of the person. Dance/movement therapists with knowledge of potential
variability of manifestations are empowered to provide clarity in treatment approaches,
documentation, and in advocacy.
A skilled dance/movement therapist is positioned to meet the client wherever they might
be on their every-changing journey. With awareness of the stages of change in substance abuse
and treatment, and knowledgeable of the trajectory of opioid abuse, dance/movement therapists
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are poised to advocate for necessary treatment for their clients. When medically assisted
treatment is available, dance/movement therapists can provide support when clients choose to
participate. If clients are hesitating, questioning efficacy of treatment, are concerned about
stigma, or do not have medically assisted treatment available, dance/movement therapists can use
their knowledge of the body-mind pathway and the biological progression of opioid use disorder
to provide insight to the client, to address barriers to treatment, and to strengthen the therapeutic
relationship. In this way, dance/movement therapists build a bridge by connecting both body to
mind and client to treatment. Dance/movement therapists also bridge the gap between the client
and the treatment team. Knowledge of the functionality of opioid use disorder positions the
dance/movement therapist as an advocate who represents the client to the treatment team in a
holistic fashion. In this way advocacy is double sided. The capacity to address biological
considerations in an embodied way helps to clarify rationale for treatment, enhances therapeutic
goal setting, increases ability to communicate concerns with the other clinicians, and in doing so,
creates space for advocacy. As specialists, representing the body-mind relationship in clinical
practice, dance/movement therapists model integration of the field of dance/movement therapy to
other disciplines and care providers.

Conclusion
Opioid use disorder is a chronic condition. There is no cure, nor is there true recovery to
the previous state. While long term abstinence is the goal, every day requires engagement in a
change of lifestyle, one in which relapse is a very real possibility. Availability of treatment and
stigmatization of abuse create challenges which make both acute and long term treatment a rocky
road for many. Dance/movement therapy gives simultaneous attention to emotional, physical,
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and social wellbeing. It also has documented neurological implications including encouraging
neuroplasticity through motoric learning. These multilevel engagements make dance/movement
therapy an effective modality for opioid use disorder treatment. For these reasons, when possible,
dance/movement therapy needs to take advantage of every opportunity to partner with medically
assisted treatment in order to craft a truly multi-sensory whole-person approach. While
partnering with medically assisted treatment would be ideal, realistically, due to incorrect
assumptions, slow adoption, and stigma, dance/movement therapists will find themselves
working as part of a system or with clients who do not have access to, or a desire to use
medically assisted treatment. In any case, dance/movement therapy, offers embodied action,
exploration, and understanding to participants so that they might engage in a learning process for
life long wellness.
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